These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3872651)

  • 1. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor.
    Hashemi SM; Hassan ZM; Soudi S; Shahabi S
    Cell Biol Int; 2008 Jul; 32(7):835-40. PubMed ID: 18455932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Poindron P
    Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.
    Ogura T; Namba N; Hirao F; Yamamura Y; Azuma I
    Cancer Res; 1979 Nov; 39(11):4706-12. PubMed ID: 498096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
    Adler A; Keisari Y; Ofir R
    J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible mechanism of tumor regression in cisplatin-treated mice.
    Sarna S; Sodhi A; Bhola RK
    Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant alpha-interferon-gelatin conjugate on in vivo murine tumor cell growth.
    Tabata Y; Uno K; Yamaoka T; Ikada Y; Muramatsu S
    Cancer Res; 1991 Oct; 51(20):5532-8. PubMed ID: 1833052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on metastases. I. Role of sensitization and immunosuppression.
    Seshadri M; Poduval TB; Sundaram K
    J Natl Cancer Inst; 1979 Nov; 63(5):1205-10. PubMed ID: 291748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
    Shiku H; Bean MA; Old LJ; Oettgen HF
    J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the cellular immune response to simian virus 40 tumor cells in tumor-bearing and tumor-immune mice by concanavalin A.
    Davis S; Boone CW
    J Natl Cancer Inst; 1975 Feb; 54(2):435-8. PubMed ID: 163333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.